< 1 minute read
Dec. 20, 2021

BIIB091: a Reversible BTK Inhibitor

BIIB091

oral reversible BTK kinase inhibitor Ph. I candidate for multiple sclerosis from prior BTK inhibitor BIIB0685 Journal of Medicinal Chemistry Biogen

drughunter.com
Drug Hunter Team
Loading...

twitterlinkedinemail

Other molecules you may be interested in